Robo Medical Launches EndoFaster: China's First Integrated Digestive Endoscopy Surgical Robot

With the widespread adoption of early gastrointestinal cancer screening technologies,Endoscopic Submucosal Dissection(ESD), as a core modality of minimally invasive therapy, by virtue of itsMinimal Trauma, Functional Preservation, and Rapid Recoveryadvantages, has become a treatment for early-stage gastrointestinal tumors"Gold Standard". However, the high operational complexity, insufficient stability of the surgical field, and long learning curve associated with ESD technology have long hindered its widespread adoption in primary care hospitals, resulting in unequal access to high-quality treatment for patients.

Natural orifice surgical robots are currently the focus and challenge of surgical robot research and development. To break through this bottleneck, Shenzhen ROBO Medical Technology Co., Ltd. (hereinafter referred to as “ROBO Medical”) has innovatively launchedEndoFaster: China's First Integrated Digestive Endoscopic Surgical Robot System, flexible robotic arm + four-degree-of-freedom precise control, providing physicians with"The Third Hand", providing a clearer surgical field, more stable manipulation, and lower risks. This major breakthrough marks a solid step forward for China in the field of digestive endoscopic surgical robots, ushering in a new era in the diagnosis and treatment of early-stage gastrointestinal cancers.

The product obtained the Class III Medical Device Registration Certificate from the National Medical Products Administration of China in March 2025 (Registration No. Guo Xie Zhu Zhun 20253010539).As the world’s first approved and marketed digestive endoscopic surgical robot, it not only fills a technological gap in China but also demonstrates the strength and potential of Chinese intelligent manufacturing on a global scale.

April 3 (Thursday) at 19:30, the 129th edition of VCBeat New Product Review, featuring Ji Rui, Director of the Department of Gastroenterology at Qilu Hospital of Shandong University,Wu Mu, Director of Government Affairs at ROBO Medical,Shen Luping, Medical Product Manager at ROBO Medical, presents“EndoFaster: China’s First Integrated Digestive Endoscopic Surgical Robot System”Innovative Sharing and Product Promotion.

EndoFaster® Integrated Digestive Endoscopic Surgical Robot

The robot adopts an external attachment for digestive endoscopy.Flexible Robotic Arm, viaMaster-Slave Control ModeEnables 4-DOF motion of the end effector, precisely controlling the grasping position and orientation, and lifting tissues that require repeated grasping to ensure a clear surgical field and reduce surgical risks. This product featuresSimple design, easy operation, and low costand other advantages,It holds positive significance for advancing the early diagnosis and treatment of early-stage gastrointestinal cancers in China, thereby reducing the societal healthcare burden of gastrointestinal cancers.

Although this robot is not a true soft surgical robot for the diagnosis and treatment of the digestive tract,Integrating existing flexible endoscopes can still bring revolutionary advancements to highly challenging digestive endoscopic surgeries., reducing surgical complexity and simplifying procedures, with the potential to enable county-level hospitals to perform them.High-Difficulty Digestive Endoscopic Surgery。

Product Advantages:

① Universality

Pioneering an externally mounted flexible robotic arm design that seamlessly integrates with existing endoscopy systems without altering physicians' operational habits.
② Master-Slave Control Mode

The physician’s hand movements are precisely mapped to the lesion site. Acting as the surgeon’s “third hand,” the system enables tissue retraction, expands and stabilizes the surgical field, and reduces the risk of perforation caused by hand tremors.
③ Simplify complex surgical workflows and lower the barrier to operation

Shorten the learning curve through standardized operating procedures and intelligent feedback systems.
④ Promoting Technology Inclusivity and Standardization
Implementation in Primary Healthcare: The low-cost nature of ESD technology enables its deployment in county-level hospitals, thereby increasing the coverage of early cancer screening and treatment.
Establishing Surgical Standards: The repeatability and consistency of robotic operations facilitate the development of national technical standards in China, thereby reducing the incidence of complications.

Scan the QR code on the poster to add the assistant and schedule the live stream.

Ji Rui

Department of Gastroenterology, Qilu Hospital of Shandong University

M.D., Associate Chief Physician, Associate Professor, Master's Supervisor, Deputy Director of the Digestive Endoscopy Center.

Currently serves as a Young Committee Member of the Digestive Endoscopy Branch of the Chinese Medical Association, a Member of the Digestive Imaging Collaboration Group of the Gastroenterology Branch of the Chinese Medical Association, and a Young Committee Member of the Endoscopy Professional Committee of the China Anti-Cancer Association. He/She has presided over multiple projects, including those funded by the National Natural Science Foundation of China, sub-projects of the National Key Research and Development Program, and the Shandong Provincial Natural Science Foundation. He/She has published more than 20 SCI-indexed papers and has received one Second Prize for Scientific and Technological Progress from the Ministry of Education and one First Prize for Scientific and Technological Progress from Shandong Province.

Wu Mu

Director of Government Affairs, ROBO Medical

With 12 years of experience in government affairs and management, specializing in the field of digestive endoscopic surgical robots, responsible for leading ROBO Medical’s government-enterprise cooperation initiatives, government financing, research project applications, medical service pricing approvals, and government procurement processes.

Shen Luping
Medical Product Manager, ROBO Medical

Holding a master’s degree from Northeastern University in the United States, he joined ROBO Medical in July 2021. He is responsible for leading product planning, execution, and marketing initiatives for the company’s surgical robots; concurrently, he oversees corporate financing, clinical trial implementation, project management, and business development activities.

ROBO Medical is a medical robotics R&D enterprise that has entered the industrialization stage. Currently, ROBO has evolved into a hub for technology and talent export in the field of medical robotics. The company has accumulated expertise in flexible robotic arms, the design and control of parallel surgical robots, force feedback, machine vision, and automated surgery, and has pioneered the application of these technologies in clinical areas such as natural orifice surgery and ultrasound diagnosis.

“VCBeat New Product Showcase” is a live-streaming series dedicated to supporting healthcare companies in launching their innovative products. The mission of the series is to facilitate the milestone launch of every innovative medical product. Companies with plans to release innovative medical products or achieve significant milestones and wish to participate in the “VCBeat New Product Showcase” are invited to add our assistant for consultation.

Scan the QR code below to contact the assistant and schedule a live stream (if already added, please reach out to the assistant directly).

Scan the QR code below to download the VCBeat app and register to watch the live stream.

Send a screenshot of the live stream to the assistant to enter the lucky draw for a chance to win a [15-day trial membership of VBInsight Industry Think Tank].